Clinical Research

Includes retrospective studies looking for patterns across patient populations, radiological studies on theoretical "phantoms" (like crash dummies, but for radiation dose), SPORE-based (Specialized Programs of Research Excellence) clinical trials and lots more.
Sheets honored by the cancer center for IMRT publication
One of only five honorees.
Chen receives a UNC Health-E-NC grant
To improve survivorship services for patients with breast, colorectal, lung and prostate cancer.
Price and colleagues win a 2013 NC Cancer Hospital Endowment Fund Award
For research to reduce treatment discomfort for patients receiving radiotherapy for gynecological cancers.
News
$3.3 Million to Study Prostate Cancer Therapies
Comparative study will focus on minority, underserved populations.
Apisarnthanarax, Brady: Best poster awards at 2008 UNC Lineberger Retreat
Chen Awarded Grant to Study Heart/Prostate Factors
A formal public award announcement will be at the June RTOG meeting
Chen paper: IMRT better than Protons/CRT
In comparing IMRT, Proton and conformal therapies, they conclude that IMRT is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence.
Chera/Rosenman/Fried paper: Pre-treatment PET and chemoradiotherapy
Paper accept in Head & Neck
Chera: Squamous Cell Carcinoma paper in JCO
Nanoparticles Promise Delivery of Abandoned Cancer Drug
A team of UNC researchers developed nanoparticle carriers to successfully deliver therapeutic doses of a cancer drug that had previously failed clinical development due to pharmacologic challenges.
Sheets Wins ASCO Merit Award
Nathan Sheets, M.D. was recently selected to receive a 2012 ASCO Conquer Cancer Foundation Merit Award.
Tepper paper: IMRT and cisplatin study published in IJROBP
Phase II Trial for Stage III and IVa Head and Neck Cancer
Wang Awarded Imaging Science Grant
Wang paper: Extended Hydrogel Microparticle Circulation Time published in PNAS
Gastrointestinal Cancer SPORE
Goal: use of combined modality therapy in the treatment of diseases of the GI tract, and assessing possible biological indicators of treatment response.
Breast Cancer SPORE
Goal: use a team approach to review cases before treatment begins, rather than after treatment decisions have been made.
Zagar wins a 2013 Junior Faculty Development Award